Home › Funds › Omega Fund Management, LLC › NUVB
Omega Fund Management, LLC position in NUVB
NUVATION BIO INC · Health Care
Omega Fund Management, LLC reported holding 7,151,031 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$40.0M, representing 31.99% of its reported portfolio and ranking #1 among its reported holdings. Omega Fund Management, LLC has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Omega Fund Management, LLC's NUVB position evolved
Omega Fund Management, LLC first disclosed a stake in NUVB in Q3 2023 at 15,072,340 shares (US$20.2M). The position peaked in Q4 2025 at 8,081,089 shares, worth US$72.4M. Across 13 filings, Omega Fund Management, LLC increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 7,151,031 shares valued at US$40.0M — a reduction of -930,058 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 15.07M | $20.20M | New |
| Q4 2023 | 15.07M | $22.76M | Hold |
| Q1 2024 | 14.07M | $51.22M | Reduce |
| Q2 2024 | 13.28M | $38.77M | Reduce |
| Q3 2024 | 13.07M | $29.94M | Reduce |
| Q4 2024 | 13.07M | $34.77M | Hold |
| Q1 2025 | 13.07M | $23.01M | Hold |
| Q2 2025 | 11.04M | $21.53M | Reduce |
| Q3 2025 | 8.83M | $32.68M | Reduce |
| Q4 2025 | 8.08M | $72.41M | Reduce |
| Q1 2026 | 8.08M | $34.67M | Hold |
| Q2 2026 | 8.08M | $45.90M | Hold |
| Q3 2026 | 7.15M | $40.05M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $145.34M · Q3 2026
- Context Capital Management, LLC 52.00M sh · $53.13M · Q3 2026
- Laurion Capital Management LP 7.70M sh · $43.10M · Q3 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- Jones Hill Capital LP 4.49M sh · $25.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- Nan Fung Group Holdings Ltd 1.33M sh · $7.43M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.11M · Q3 2026
More on Omega Fund Management, LLC
FAQ
How long has Omega Fund Management, LLC held NUVB?
Omega Fund Management, LLC has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Omega Fund Management, LLC's current position in NUVB?
As of Q3 2026, Omega Fund Management, LLC holds 7.15M shares of NUVB (NUVATION BIO INC), valued at $40.05M, representing 31.99% of its reported portfolio and ranking #1.
Has Omega Fund Management, LLC been buying or selling NUVB?
In the latest 13F filing (Q3 2026), Omega Fund Management, LLC reduced its position in NUVB. The position peaked in Q4 2025 at 8.08M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.